BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31114222)

  • 1. High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center.
    Li Y; Fang D; Bao Z; He A; Guan B; He S; Zhan Y; Gong Y; Li X; Zhou L
    Onco Targets Ther; 2019; 12():2635-2648. PubMed ID: 31114222
    [No Abstract]   [Full Text] [Related]  

  • 2. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
    Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.
    Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
    Clin Genitourin Cancer; 2017 Oct; 15(5):598-604. PubMed ID: 28495053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.
    Cheng X; Zhou X; Yi M; Xu S; Zhang C; Wang G
    BMC Urol; 2021 Sep; 21(1):136. PubMed ID: 34579695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
    Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
    Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Preoperative Controlling Nutritional Status Score Predicts a Poor Prognosis in Patients with Localized Upper Tract Urothelial Cancer: A Propensity Score Matching Study in a Large Chinese Center.
    Bao Z; Li Y; Guan B; Xiong G; Zhang L; Tang Q; Wang T; Li X; Fang D; Zhou L
    Cancer Manag Res; 2020; 12():323-335. PubMed ID: 32021446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
    Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
    Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
    Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
    Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could Metabolic Syndrome Be a Predictor of Survival Outcomes in Upper Tract Urothelial Carcinoma? A Propensity Score Matching Study in a Large Chinese Center.
    Dai X; Wang F; Du Y; Qin C; Lai S; Song Y; Huang Z; Han S; Zhang X; Xu T
    Front Oncol; 2022; 12():816915. PubMed ID: 35719953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
    Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
    Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
    Nishikawa M; Miyake H; Fujisawa M
    Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment.
    Kang M; Shin SJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
    Dis Markers; 2020; 2020():8887605. PubMed ID: 32724485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients.
    Wu J; Chen L; Wang Y; Tan W; Huang Z
    Onco Targets Ther; 2019; 12():5201-5213. PubMed ID: 31308692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Value of Preoperative Naples Prognostic Score in Upper Tract Urothelial Carcinoma Patients after Radical Nephroureterectomy.
    Ye J; Chen Z; Pan Y; Liao X; Wang X; Zhang C; Wang Q; Han P; Wei Q; Bao Y
    Nutr Cancer; 2024; 76(1):80-88. PubMed ID: 37941300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
    Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
    Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective controlled observation ofeffect of adjuvant chemotherapy onsurvival and prognosis ofhigh-risk upper tract urothelial carcinoma patients underwent radical nephroureterectomy].
    Luo Y; Feng BF; Wei DC; Han YL; Li MC; Zhao JH; Lin YH; Li Q; Hou Z; Zhang GY; Jiang YG
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3158-3163. PubMed ID: 31694107
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative Systemic Inflammation Score Predicts the Prognosis of Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
    Wang Q; Ye J; Chen Z; Liao X; Wang X; Zhang C; Zheng L; Han P; Wei Q; Bao Y
    J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.